Long Covid – The Evidence For and Use of Low Dose Naltrexone
Oyungerel Byambasuren, MD, PhD
Institute for Evidence-Based Healthcare
Bond University
14 University Dr, Robina QLD 4226 Australia
Tel: 61 7 5595 4182
obyambas@bond.edu.au
“Effect of Low-Dose Naltrexone for Long COVID:
Systematic Review”, medRxiv 2025 (3/2026)
Kirk Hamilton: Can you please share with me your educational background and current position?
Oyuka Byambasuren: I am an Assistant Professor at the Institute for Evidence-Based Healthcare, Bond University, Australia. I am a medical doctor and general practitioner by background. My current work focuses on Long COVID (LC), clinical trial methodology, and improving the evidence base for primary care interventions. I recently led a systematic review examining the effectiveness of low-dose naltrexone for Long COVID. Continue reading What is the Evidence for the Use of Low Dose Naltrexone (LDN) in Long Covid – An Interview with Oyungerel Byambasuren, MD, PhD